sc-rDSeq: a robust and cost-effective full-length total RNA sequencing method for single cells reveals multilayered heterogeneity in drug-resistant lung cancer cells
Nucleic Acids Research · 13.04.2026 · 54 (7)
DOI: 10.1093/nar/gkag312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 13.04.2026. Verfasst von Xue Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University, 9190401 Jerusalem, Israel. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Lung Neoplasms, Sequence Analysis, RNA, Single-Cell Analysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, Israeli Center of Research Excellence, Israel Science Foundation.
Abstract (Originalsprache)
sc-rDSeq is a scalable, full-length total RNA droplet-based technology that captures both polyadenylated and nonpolyadenylated RNAs, including histone RNAs, small and long non-coding RNAs, and enhancer RNAs. It achieves a 10-fold increase in UMIs per cell compared to conventional scRNAseq like 10× Chromium and inDrops, while remaining simple and cost-efficient. Applied to lung cancer cells, sc-rDSeq uncovered hidden heterogeneity, divergent signaling pathways, and non-polyA RNA variations undetectable by 3′ end-based methods. Following EGFR inhibitor treatment, cell cycle arrest was detected through non-polyA histone messenger RNA expression, revealing seven distinct subpopulations of cells with upregulation of different persister-related programs, like migration, sterol synthesis and matrix formation. Additionally, by leveraging single-cell expression variability and pseudo-bulk analyses, sc-rDSeq unveiled alternative splicing events and single nucleotide variations that distinguished the drug resistant subsets. sc-rDSeq therefore opens the way for in-depth personalized medicine applications through massive-scale and multifaceted analysis of different RNA species, splicing events, and sequence variations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University, 9190401 Jerusalem, Israel.
ORCID-Profile: Oren Ram
Förderung
- European Research Council
- Israeli Center of Research Excellence
- Israel Science Foundation
- Azriely Foundation Scholar Program
- ERC
Zitieren
APA
Sun, X., Dadon, S. L., Ennis, D., Fan, W., Awawdy, M., Reuveni, E., Alajem, A., & Ram, O. (2026). sc-rDSeq: a robust and cost-effective full-length total RNA sequencing method for single cells reveals multilayered heterogeneity in drug-resistant lung cancer cells. Nucleic Acids Research, 54(7). https://doi.org/10.1093/nar/gkag312
Vancouver
Sun X, Dadon SL, Ennis D, Fan W, Awawdy M, Reuveni E, et al. sc-rDSeq: a robust and cost-effective full-length total RNA sequencing method for single cells reveals multilayered heterogeneity in drug-resistant lung cancer cells. Nucleic Acids Research. 2026;54(7). doi:10.1093/nar/gkag312
BibTeX
@article{Sun2026,
author = {Sun, Xue and Dadon, Shir-Liya and Ennis, Dena and Fan, Wenpeng and Awawdy, Muhammad and Reuveni, Eli and Alajem, Adi and Ram, Oren},
title = {sc-rDSeq: a robust and cost-effective full-length total RNA sequencing method for single cells reveals multilayered heterogeneity in drug-resistant lung cancer cells},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {7},
doi = {10.1093/nar/gkag312}
}
EUVIMED